Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Primary Care
•
General Primary Care
•
Women
How do you approach the risk/benefit discussion with patients when you are considering starting menopausal HRT?
Particularly in low risk patient in regards to typical ASE of HRT.
Related Questions
What symptom or constellation of symptoms are most specific for endometriosis that should prompt further workup?
How do you decide whether average-risk patients should undergo annual or biennial breast cancer screening?
Do you start bisphosphonates after tapering off menopausal hormone therapy to prevent the rapid decline of bone mineral density?
What is your go-to strategy for non-opioid management of chronic low back pain in patients with limited access to physical therapy or behavioral health?
What strategy do you find most effective for outpatient induction of buprenorphine in opioid use disorder?
Do you recommend starting with oral or intramuscular B12 supplementation in patients with newly diagnosed deficiency?
In addition to optimizing a three drug regimen (thiazide, CCB, ACE-I/ARB) what other workup or management do you recommend for a young patient with obesity and a new diagnosis of hypertension well outside goal range?
How do you determine whether to limit volume removal during therapeutic paracentesis in a patient without acute or chronic kidney disease?
What is your next step in management for patients who develop sexual side effects on an SSRI (anorgasmia, low libido, etc.) but are responding well to therapy?
When (if ever) do you recommend taping a patient off of buprenorphine after sustained remission?